Top Markets
Coin of the day
Aida Pharmaceuticals, Inc. Aida Pharmaceuticals, Inc.

Aida Pharmaceuticals, Inc.

AIDA
Rang in Aktien #41891
Aida Pharmaceuticals, Inc., together with its affiliates, operates extensively... Aida Pharmaceuticals, Inc., together with its affiliates, operates extensively throughout mainland China, specializing in the entire spectrum of pharmaceutical and genetic product development. This encompasses formulation, clinical trials, regulatory registration, manufacturing, sales, and marketing. The company's diverse product range includes antibiotics, cardiovascular medicines, and anti-cancer drugs. These are available in various forms, such as injectable powders, intravenous liquids, capsules, tablets, and ointments. Notable products feature Etimicin Sulfate, provided as an injectable powder, and rh-Apo2l, a biopharmaceutical therapy targeting cancers. Established in 1999, Aida Pharmaceuticals, Inc. is headquartered in Hangzhou, China.
Aktienkurs
$0.0003
Zuletzt synchronisiert: 2026-08-11
Marktkapitalisierung
$8.10K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
50.00%
Land
CN
Handel Aida Pharmaceuticals, Inc. (AIDA)

Kategorie

EPS für Aida Pharmaceuticals, Inc. (AIDA)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von Aida Pharmaceuticals, Inc. beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von Aida Pharmaceuticals, Inc. von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber